1.Relationship Between A Body Shape Index,Bone Mineral Density,Osteoporosis,and Fracture Risk in Middle-aged and Elderly Adults:Evidence from NHANES 2017-2020
Jiehua LUO ; Haoze GAO ; Qipei LIU
Journal of Medical Research 2025;54(9):128-134
Objective To investigate the relationship between a body shape index(ABSI),bone mineral density(BMD),osteopo-rosis,and fracture risk,and to evaluate its potential value as a predictive marker for skeletal health risks in middle-aged and elderly in-dividuals.This study aims to provide scientific evidence for the early screening and intervention of osteoporosis and fracture risks.Meth-ods Using data from the National Health and Nutrition Examination Survey(NHANES)2017-2020,individuals aged ≥50 years were selected as the study population.ABSI was calculated and categorized into quartiles.The relationship between ABSI and fracture risk was analyzed using logistic regression models while adjusting for demographic characteristics,lifestyle factors,and clinical variables.A re-stricted cubic spline(RCS)model was employed to explore the dose-response relationship between ABSI and fracture risk.Subgroup an-alyses were conducted to identify potential effect modifiers.Results BMD decreased,and the risks of osteoporosis and fractures signifi-cantly increased with higher ABSI quartiles(trend P<0.05).Compared to the lowest ABSI quartile,individuals in the highest quartile had a significantly increased fracture risk(adjusted OR=1.33,95%CI:1.04-1.70).RCS analysis demonstrated a linear positive cor-relation between ABSI and fracture risk(overall P<0.001),with fracture risk progressively increasing with higher ABSI levels.Sub-group analyses revealed consistent associations across different age groups,sexes,and BMI categories.Conclusion ABSI is independ-ently associated with lower BMD,higher osteoporosis risk,and increased fracture risk.These findings suggest that ABSI is a simple and effective tool for identifying individuals at high skeletal health risk,providing scientific evidence for the early prevention and intervention of osteoporosis and fractures.
2.Relationship Between A Body Shape Index,Bone Mineral Density,Osteoporosis,and Fracture Risk in Middle-aged and Elderly Adults:Evidence from NHANES 2017-2020
Jiehua LUO ; Haoze GAO ; Qipei LIU
Journal of Medical Research 2025;54(9):128-134
Objective To investigate the relationship between a body shape index(ABSI),bone mineral density(BMD),osteopo-rosis,and fracture risk,and to evaluate its potential value as a predictive marker for skeletal health risks in middle-aged and elderly in-dividuals.This study aims to provide scientific evidence for the early screening and intervention of osteoporosis and fracture risks.Meth-ods Using data from the National Health and Nutrition Examination Survey(NHANES)2017-2020,individuals aged ≥50 years were selected as the study population.ABSI was calculated and categorized into quartiles.The relationship between ABSI and fracture risk was analyzed using logistic regression models while adjusting for demographic characteristics,lifestyle factors,and clinical variables.A re-stricted cubic spline(RCS)model was employed to explore the dose-response relationship between ABSI and fracture risk.Subgroup an-alyses were conducted to identify potential effect modifiers.Results BMD decreased,and the risks of osteoporosis and fractures signifi-cantly increased with higher ABSI quartiles(trend P<0.05).Compared to the lowest ABSI quartile,individuals in the highest quartile had a significantly increased fracture risk(adjusted OR=1.33,95%CI:1.04-1.70).RCS analysis demonstrated a linear positive cor-relation between ABSI and fracture risk(overall P<0.001),with fracture risk progressively increasing with higher ABSI levels.Sub-group analyses revealed consistent associations across different age groups,sexes,and BMI categories.Conclusion ABSI is independ-ently associated with lower BMD,higher osteoporosis risk,and increased fracture risk.These findings suggest that ABSI is a simple and effective tool for identifying individuals at high skeletal health risk,providing scientific evidence for the early prevention and intervention of osteoporosis and fractures.
3.Epidemiological characteristics of respiratory syncytial virus among inpatients in a children′s hospital in Shenzhen City from 2020 to 2023
Xiaojuan LUO ; Wei WANG ; Zhenmin REN ; Xiaoying FU ; Yunsheng CHEN ; Wenjian WANG ; Yanmin BAO ; Yuejie ZHENG ; Ke CAO ; Jiehua CHEN
Chinese Journal of Preventive Medicine 2025;59(4):484-489
This study analyzed the epidemiological characteristics and trends of respiratory syncytial virus (RSV) infections among inpatients with acute respiratory infections (ARI) in a children′s hospital in Shenzhen City inpatients from 2020 to 2023. From January 2020 to December 2023, multiple reverse transcription polymerase chain reaction (RT-PCR) combined with capillary electrophoresis fragment analysis technology was used to detect the nucleic acids of 12 respiratory pathogens, including RSV, in hospitalized children diagnosed with ARI. The patients were divided into six age groups: 0 to <6 months, 6 months to <1 year, 1 to <2 years, 2 to <5 years, 5 to <10 years, and 10 to <18 years. A total of 53 033 children were tested, including 6 830 RSV positive cases, with an overall positivity rate of 12.88%. The annual RSV positivity rates from 2020 to 2023 were 20.04%, 16.18%, 4.89%, and 13.33%, respectively, with statistically significant differences between the years ( χ2=1 185.994, P<0.001). The positive rate of RSV detection decreased with increasing age across all years (all P trend<0.05). From 2020 to 2023, the proportion of RSV-positive cases aged 2 to 5 years and older showed an increasing trend ( P trend<0.001 for all years). Compared to 2023, the median age of RSV-infected children was lower in 2020 ( Z=7.826, P<0.001) and 2021 ( Z=6.106, P<0.001). The proportion of severe infections requiring ICU admission did not change significantly across all years ( χ2=0.179, P=0.981). The RSV epidemic season in 2020 mainly occurred during 28-43 weeks, and in 2021, it spanned from 22-43 weeks. However, in 2022, the season was delayed until the 49th week and lasted for three weeks. In 2023, the seasonal epidemic appeared earlier, starting in the 14th week and lasting for 28 weeks. From 2020 to 2023, the rate of RSV co-infections with other pathogens (mycoplasma pneumoniae, human parainfluenza virus, human bocavirus, human coronavirus, human metapneumovirus, and influenza A) significantly increased (all P trend<0.01). In conclusion, the epidemiological characteristics of RSV infections in Shenzhen Children′s Hospital changed from 2020 to 2023. In 2022, there were only delayed, low-intensity and short-lived seasonal epidemics. However, in 2023, there was an earlier and prolonged epidemic, with increased infections in children aged 2 to 5 years and older and a rise in co-infections, while the proportion of severe infections requiring ICU admission remained unchanged.
4.Epidemiological characteristics of respiratory syncytial virus among inpatients in a children′s hospital in Shenzhen City from 2020 to 2023
Xiaojuan LUO ; Wei WANG ; Zhenmin REN ; Xiaoying FU ; Yunsheng CHEN ; Wenjian WANG ; Yanmin BAO ; Yuejie ZHENG ; Ke CAO ; Jiehua CHEN
Chinese Journal of Preventive Medicine 2025;59(4):484-489
This study analyzed the epidemiological characteristics and trends of respiratory syncytial virus (RSV) infections among inpatients with acute respiratory infections (ARI) in a children′s hospital in Shenzhen City inpatients from 2020 to 2023. From January 2020 to December 2023, multiple reverse transcription polymerase chain reaction (RT-PCR) combined with capillary electrophoresis fragment analysis technology was used to detect the nucleic acids of 12 respiratory pathogens, including RSV, in hospitalized children diagnosed with ARI. The patients were divided into six age groups: 0 to <6 months, 6 months to <1 year, 1 to <2 years, 2 to <5 years, 5 to <10 years, and 10 to <18 years. A total of 53 033 children were tested, including 6 830 RSV positive cases, with an overall positivity rate of 12.88%. The annual RSV positivity rates from 2020 to 2023 were 20.04%, 16.18%, 4.89%, and 13.33%, respectively, with statistically significant differences between the years ( χ2=1 185.994, P<0.001). The positive rate of RSV detection decreased with increasing age across all years (all P trend<0.05). From 2020 to 2023, the proportion of RSV-positive cases aged 2 to 5 years and older showed an increasing trend ( P trend<0.001 for all years). Compared to 2023, the median age of RSV-infected children was lower in 2020 ( Z=7.826, P<0.001) and 2021 ( Z=6.106, P<0.001). The proportion of severe infections requiring ICU admission did not change significantly across all years ( χ2=0.179, P=0.981). The RSV epidemic season in 2020 mainly occurred during 28-43 weeks, and in 2021, it spanned from 22-43 weeks. However, in 2022, the season was delayed until the 49th week and lasted for three weeks. In 2023, the seasonal epidemic appeared earlier, starting in the 14th week and lasting for 28 weeks. From 2020 to 2023, the rate of RSV co-infections with other pathogens (mycoplasma pneumoniae, human parainfluenza virus, human bocavirus, human coronavirus, human metapneumovirus, and influenza A) significantly increased (all P trend<0.01). In conclusion, the epidemiological characteristics of RSV infections in Shenzhen Children′s Hospital changed from 2020 to 2023. In 2022, there were only delayed, low-intensity and short-lived seasonal epidemics. However, in 2023, there was an earlier and prolonged epidemic, with increased infections in children aged 2 to 5 years and older and a rise in co-infections, while the proportion of severe infections requiring ICU admission remained unchanged.
5.Preparation and Performance of a Novel Polyurethane Microporous Film on Polypropylene Medical Mesh Surface
Chenxu TIAN ; Feng LUO ; Jiehua LI ; Xueling HE
Journal of Sichuan University (Medical Sciences) 2024;55(4):853-860
Objective This study aims to develop a medical patch surface material featuring a microporous polyurethane(PU)membrane and to assess the material's properties and biological performance.The goal is to enhance the clinical applicability of pelvic floor repair patch materials.Methods PU films with a microporous surface were prepared using PU prepolymer foaming technology.The films were produced by optimizing the PU prepolymer isocyanate index(R value)and the relative humidity(RH)of the foaming environment.The surface morphology of the PU microporous films was observed by scanning electron microscopy,and the chemical properties of the PU microporous films,including hydrophilicity,were analyzed using infrared spectroscopy,Raman spectroscopy,and water contact angle measurements.In vitro evaluations included testing the effects of PU microporous film extracts on the proliferation of L929 mouse fibroblasts and observing the adhesion and morphology of these fibroblasts.Additionally,the effect of the PU microporous films on RAW264.7 mouse macrophages was studied.Immune response and tissue regeneration were assessed in vivo using Sprague Dawley(SD)rats.Results The PU films exhibited a well-defined and uniform microporous structure when the R value of PU prepolymer=1.5 and the foaming environment RH=70%.The chemical structure of the PU microporous films was not significantly altered compared to the PU films,with a significantly lower water contact angle([55.7±1.5]°)compared to PU films([69.5±1.7]°)and polypropylene(PP)([104.3±2.5]°),indicating superior hydrophilicity.The extracts from PU microporous films demonstrated good in vitro biocompatibility,promoting the proliferation of L929 mouse fibroblasts.The surface morphology of the PU microporous films facilitated fibroblast adhesion and spreading.The films also inhibited the secretion of tumor necrosis factor-α(TNF-α)and interleukin(IL)-1β by RAW264.7 macrophages while enhancing IL-10 and IL-4 secretion.Compared to 24 hours,after 72 hours of culture,the expression levels of TNF-α and IL-1β were reduced in both the PU film and PU microporous film groups and were significantly lower than those in the PP film group(P<0.05),with the most notable decreases observed in the PU microporous film group.IL-10 and IL-4 levels increased significantly in the PU microporous film group,surpassing those in the PP film group(P<0.01),with the most pronounced increase in IL-4.The PU microporous film induced mild inflammation with no significant fibrous capsule formation in vivo.After 60 days of implantation,the film partially degraded,showing extensive collagen fiber growth and muscle formation in its central region.Conclusion The PU microporous film exhibits good hydrophilicity and biocompatibility.Its surface morphology enhances cell adhesion,regulates the function of RAW264.7 macrophages,and promotes tissue repair,offering new insights for the design of pelvic floor repair and reconstruction patch materials.
6.Endovascular Management of Aortic Arch Diseases: Current Status and Future Trends
Chang SHU ; Jiehua LI ; Mingyao LUO ; Quanming LI ; Kun FANG
Cardiology Discovery 2022;02(4):263-268
Treatment of aortic arch (AA) diseases is challenging for surgeons. Conventional open surgery remains the "gold standard" but is associated with significant morbidity and mortality despite improvements in techniques. In the last 2 decades, thoracic endovascular aortic repair (TEVAR) has become the first-line treatment for diseases of the descending aorta, and its indications have expanded gradually. Various strategies have been proposed to preserve supra-aortic branches in TEVAR: hybrid technique, chimney technique, fenestration technique (including custom-made fenestrated or "scalloped" stent grafts, in situ fenestration, and physician-modified fenestration), and branched stent grafts. Though acceptable outcomes of endovascular aortic repair have been documented, the evidence regarding its long-term safety and efficacy is lacking, and concerns remain about the risk of cerebrovascular events, retrograde type-A dissection, endoleaks, and branch occlusion. This review discusses the current status and progress of endovascular repair of the AA, and looks toward future trends. We believe that multidisciplinary collaboration of a "HENDO" team (professionals in hybrid repair, endovascular repair, open surgery, cardiovascular anesthesia, and genetics) is essential for future repair of the AA to provide the optimal treatment.
7.Endovascular Management of Aortic Arch Diseases: Current Status and Future Trends
Chang SHU ; Jiehua LI ; Mingyao LUO ; Quanming LI ; Kun FANG
Cardiology Discovery 2022;02(4):263-268
Treatment of aortic arch (AA) diseases is challenging for surgeons. Conventional open surgery remains the "gold standard" but is associated with significant morbidity and mortality despite improvements in techniques. In the last 2 decades, thoracic endovascular aortic repair (TEVAR) has become the first-line treatment for diseases of the descending aorta, and its indications have expanded gradually. Various strategies have been proposed to preserve supra-aortic branches in TEVAR: hybrid technique, chimney technique, fenestration technique (including custom-made fenestrated or "scalloped" stent grafts, in situ fenestration, and physician-modified fenestration), and branched stent grafts. Though acceptable outcomes of endovascular aortic repair have been documented, the evidence regarding its long-term safety and efficacy is lacking, and concerns remain about the risk of cerebrovascular events, retrograde type-A dissection, endoleaks, and branch occlusion. This review discusses the current status and progress of endovascular repair of the AA, and looks toward future trends. We believe that multidisciplinary collaboration of a "HENDO" team (professionals in hybrid repair, endovascular repair, open surgery, cardiovascular anesthesia, and genetics) is essential for future repair of the AA to provide the optimal treatment.
8.Finite-element investigation on center of resistance of maxillary anterior teeth.
Jiehua SU ; Jiali LIU ; Duangqiang ZHANG ; Gusheng LUO ; Libing CHEN ; Xiaonan YU ; Zhiwei LIN ; Jian ZHANG
Journal of Biomedical Engineering 2014;31(5):994-1000
A three-dimensional finite element model of premaxillary bone and anterior teeth was established with ANSYS 13.0. The anterior teeth were fixed with strong stainless labial archwire and lingual frame. In the horizontal loading experiments, a horizontal retraction force of 1.5 N was applied bilaterally to the segment through hooks at the same height between 7 and 21 mm from the incisal edge of central incisor; in vertical loading experiments, a vertical intrusion force of 1.5 N was applied at the midline of lingual frame with distance between 4 and 16 mm from the incisal edge of central incisor. After loading, solution was done and displacement and maximum principle stress were calculated. After horizontal loading, lingual displacement and stress in periodontal membrane (PDM) was most homogeneous when the traction force was 14 mm from the edge of central incisor; after vertical loading, intrusive displacement and stress in PDM were most homogeneous when the traction force was 12 mm from the incisal edge of central incisor. The results of this study suggested that the location of center of resistance (CRe) of six maxillary anterior teeth is about 14 mm gingivally and 12 mm lingually to incisal edge of central incisor. The location can provide evidence for theoretical and clinical study in orthodontics.
Dental Models
;
Dental Stress Analysis
;
Finite Element Analysis
;
Humans
;
Incisor
;
Maxilla
;
Periodontal Ligament
;
Tongue
9.Research of postoperative epidural analgesia for sufentanil combined with ropivacaine under lower limb surgery in elderly
Jiehua FENG ; Chaoyang LI ; Dong WU ; Jie AO ; Jingjing MU ; Xiaomin LUO
Chinese Journal of Postgraduates of Medicine 2011;34(12):8-10
Objective To investigate the safty and proper concentration of using the sufentanil combined with ropivacaine in patient-controlled epidural analgesia (PCEA) under lower limb surgery in elderly. Methods Eighty patients scheduled for lower limb surgery were divided into 4 groups by random digits table with 20 cases in each. The concentration of the sufentanil were 0.1,0.2,0.3 and 0.4 μ g/ml in group A, B, C, D respectively. The concentration of the ropivacaine were 0.125% in each group for the PCEA.R-VAS, C-VAS , Bromage score, Ramsay score, press times ,dosage and side effects were monitored and recorded at 4,10,24 and 48 h after operation. Results Compared with those in group C, D, C-VAS,dosage of the analgesia,press times of PCEA were higher in group A,B (P<0.01 or < 0.05),the efficacy of press was lower in group A, B(P<0.05), but there was no significant difference between group C and group D(P>0.05 ).The Ramsay score 10,24 h after operation in group D[(4.5 ± 0.5 ), (4.6 ± 0.6) scores] was higher than that in group A,B,C [(2.7 ±0.8), (2.7 ±0.8) scores vs.(2.9 ± 0.9), (2.7 ± 0.9) scores vs. (3.0 ±0.7), (2.9 ±0.5) scores] (P <0.05). There were no case with hypotension and respiratory depression.Conclusion PCEA of four methods are safe and effective in elderly which 0.3 μ g/ml sufentanil combined with 0.125% ropivacaine have good analgesic effect and less side effect.
10.Synthesis and characterization of PEG-segmented polyurethane.
Jianbin LUO ; Peng WANG ; Jiehua LI ; Xingyi XIE ; Cuirong FAN ; Chengsheng HE ; Yinping ZHONG
Journal of Biomedical Engineering 2006;23(1):125-128
PEG (Mn = 1000)-segmented polyurethanes, with hard segment percentage of 40%, 50% and 55% and named PU-H40, PU-H50 and PU-H55 respectively, were synthesized by bulk polymerization. The structure of PU was characterized by FTIR, DSC, and GPC. Mechanical properties, water contact angles and water vapor transmit rate(WVTR) were also tested. FTIR and DSC showed that the degree of microphase separation increased with the hard content. Mechanical test showed the tensile strength of PU-H50 to be 25 MPa, the highest tensile strength of the PU series. By the use of PEG as soft segment, the surface hydrophilicity of the materials increased dramatically. Owing to its high degree of microphase separation and the mobility of soft segment, the water contact angle of PU-H55 attained to 33 degrees. The WVTRs of PU-H40, PU-H50 and PU-H55 were 789 g/m2/24h, 705 g/m2/24h and 623g/m2/24h respectively. These data suggest that the materials are suitable for fabricating such biomedical articles as surgical gloves, wound dressing and medical protective coating.
Biocompatible Materials
;
chemical synthesis
;
chemistry
;
Humans
;
Polyethylene Glycols
;
chemistry
;
Polyurethanes
;
chemical synthesis
;
chemistry
;
Spectroscopy, Fourier Transform Infrared
;
Surface Properties

Result Analysis
Print
Save
E-mail